Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Roselyn Kellen"'
Autor:
Roselyn Kellen, Nanette B. Silverberg
Publikováno v:
Harper's Textbook of Pediatric Dermatology
Autor:
Roselyn Kellen, Joshua M. Berlin
Publikováno v:
Journal of the Dermatology Nurses' Association. 10:164-173
Autor:
Amira Elbendary, Roselyn Kellen
Publikováno v:
Journal of Psoriasis and Psoriatic Arthritis. 2:65-72
Over the past decade or so, the treatment of patients with psoriasis has been revolutionized by the development of the biological agents, monoclonal antibodies that target specific aspects of the inflammatory cascades. The biologic agents approved by
Autor:
Amira Elbendary, Roselyn Kellen
Publikováno v:
Journal of Psoriasis and Psoriatic Arthritis. 2:31-37
Over the past decade or so, the treatment of patients with psoriasis has been revolutionized by the development of the biological agents, monoclonal antibodies that target specific aspects of the inflammatory cascades. The biologic agents approved by
Publikováno v:
Pediatric Health, Medicine and Therapeutics
The biologic agent ustekinumab is a human monoclonal antibody that binds to the p40 subunit shared by interleukins (ILs) 12 and 23. The antibody is able to prevent binding of cytokines to the IL-12Rβ1 cell surface receptor and therefore may prevent
Publikováno v:
Journal of Psoriasis and Psoriatic Arthritis. 1:112-122
Psoriasis is a chronic disease that affects approximately 2.2% of the U.S. population. The annual economic burden of this disease, both on an individual and national level, has not been clearly defined. Two recently published articles estimated the a
Autor:
Tatyana Nektalova, Roselyn Kellen
Publikováno v:
Journal of Psoriasis and Psoriatic Arthritis. 1:96-101
Psoriasis is a chronic skin disorder with an autoimmune component primarily driven by overactive T cells culminating in an excessive inflammatory response. Patients have reported clearance of their psoriasis after organ transplant, due to their maint
Autor:
Roselyn, Kellen, Nanette B, Silverberg
Publikováno v:
Cutis. 100(6)
Periorificial dermatitis (POD) has been documented in the pediatric population in patients as young as 3 months, with a slight predominance in girls compared to boys. Many patients have a personal or family history of atopic disorders. Periorificial